-- 
Bioline, Hapoalim, Bezeq, Africa-Israel: Israeli Equity Preview

-- B y   S h a r o n   W r o b e l
-- 
2011-07-03T06:36:46Z

-- http://www.bloomberg.com/news/2011-07-03/bioline-hapoalim-bezeq-africa-israel-israeli-equity-preview.html
The following stocks may rise or fall
in Israeli markets. Stock symbols are in parentheses after
company names and prices are from the last close unless
otherwise stated.  The TA-25 Index fell 0.4 percent to 1,223.91 in Tel Aviv.  Africa-Israel Investments Ltd. (AFIL)  : The holding
company completed the purchase of an additional 5.1 percent
stake in AFI Development Plc for $64 million. Africa-Israel
retreated 2.2 percent to 21.23 shekels.  Bezeq The Israeli Telecommunication Corp. (BEZQ IT): The
country’s largest communications company said it raised gross
proceeds of 2.71 billion shekels ($802 million) from the sale of
bonds. Bezeq rose 0.2 percent to 8.574 shekels.  Bioline RX Ltd. (BLRX)  : The biopharmaceutical
development company filed a request to the U.S. Securities and
Exchange Commission to withdraw a planned sale of shares in the
U.S. Bioline declined 2.1 percent to 1.636 shekels.  Bank Hapoalim Ltd. (POLI IT): The country’s second-largest
bank by assets approved a 270 million-shekel dividend payable
July 27. Hapoalim fell 1.1 percent to 16.92 shekels.  Israel Petrochemical Enterprises Ltd. (PTCH)  : A unit of
the maker of raw materials for the plastic industry completed
the purchase of a 1.9 percent stake in  Avgol Industries 1953
Ltd. (AVGL)   for 10 million shekels. Israel Petrochemical
dropped 3.4 percent to 11.21 shekels. Avgol slipped 0.3 percent
to 2.773 shekels.  Koor Industries Ltd. (KOR)  : The holding company signed
an agreement for a $960 million loan under terms of the sale of
a stake in  Makhteshim-Agan Industries Ltd. (MAIN)   to China
National Chemical Corp. Koor advanced 0.3 percent to 65 shekels.
Makhteshim dropped 0.3 percent to 19 shekels.  Shamir Optical Industry (SHMR IT): Essilor International
completed the acquisition of a 50 percent stake in the provider
of technology for the ophthalmic lens industry. Shamir was
unchanged at 48.66 shekels.  To contact the reporter on this story:
Sharon Wrobel in  Tel Aviv  at 
 swrobel4@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  